We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
1 hedge funds and large institutions have $4.87K invested in Windtree Therapeutics in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
75% less funds holding
Funds holding: 4 → 1 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
98% less capital invested
Capital invested by funds: $239K → $4.87K (-$234K)
Holders
1
Holders Change
-3
Holders Change %
-75%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.04K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$215K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$4.95K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.77K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$15 |